Barinthus Biotherapeutics plc. — Director's Dealing 2021

May 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaccitech plc (VACC)
CIK: 0001828185
Period of Report: 2021-04-29

Reporting Person: Griffiths Graham (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-29	Share Option (Right to Buy)	$17	A	6054	Acquired	2031-04-29	Ordinary Shares (6054)	Direct
2021-04-29	Share Option (Right to Buy)	$17	A	88065	Acquired	2031-04-29	Ordinary Shares (88065)	Direct

Footnotes

F1: This option shall vest and become exercisable on April 29, 2022.

F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3: This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on April 29, 2022.